Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 50, 1995 - Issue 2
3
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Pathogenesis of IgA Nephropathy

Pages 71-75 | Published online: 20 May 2016

References

  • Berger J, Hinglais N. Les depots intercapillaires d’IgA-IgG. J Urol Nephrol. 1968; 74: 694–5.
  • Mustonen J, Pasternak A. Associated diseases in IgA nephropathy. In: IgA nephropathy.edited by Clarkson AR. Martinus Nijhoff Publishing, Boston, Dordrecht, Lancaster, 1987, pp 47–65.
  • Odum J, Peh CA, Clarkson AR et al. Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant. 1994; 9: 309–12.
  • Silva FG, Chander P, Pirani CL, Hardy MA. Disappearance of glomerular inesangial IgA deposits after renal allograft transplantation. Transplantation. 1982; 33: 241–6.
  • Clarkson AR. IgA nephropathy: history, classification and geographic distribution. In: IgA nephropathy, edited by Clarkson AR. Martinus Nijhoff Publishing. Boston, Dordrecht, Lancaster. 1987. pp 1–8.
  • Egido J.Sancho J.Mampaso F, et al. A possible common pathogenesis of the mesangial IgA glomerulonephritis in patients with Berger’s disease and Schflnlein-Henoch syndrome. Proc Eur Dial Transplant Assoc. 1980; 17: 660–6.
  • Tomino Y, Endoh M, Nomoto Y, Sakai H. Immunoglobulin Al and IgA nephropathy. N Engl J Med. 1981; 305: 1159–60.
  • Emancipator SN. IgA nephropathy: morphologic expression and pathogenesis. Am J Kidney Dis. 1994;23:451–62.
  • Monteiro RC, Albwachs-Mecarelli L, Roquc-Barreira MC, Noel LH, Bergcr J, Lesavre P. Charge and size of mesangial IgA in IgA nephropathy. Kidney Int. 1985;28:666–71.
  • Davin JC. Contribution & l’dtude de la pathogdnie des nephropathies a IgA. Thiised’Aggregation. Universite de Lifege. 1993.
  • Scivittaro V, Amore A, Emancipator SN. Animal models as a mean to study IgA nephropathy. Contrib Nephrol. 1993; 104: 65–78.
  • Stockert RJ, KressnerMS, Collins JC, Sternlieb I, Morell AG. IgA interaction with the asialoglycoprotein receptor. Proc Natl Acad Sci USA. 1982; 79: 6229–31.
  • Delacroix DL. The human immunogloglobulin A system. Its vascular compartment. Thesis. European Medical Press, Brugge, 1985.
  • Davin JC, Forget P, Mahieu PR. Increased intestinal permeability to (51 Cr) EDTA is correlated with IgA immune complex-plasma levels in children with IgA-associatcd nephropathies. Acta Paediatr Scand. 1988; 77: 118–24.
  • Davin JC, Foidart JB, Mahieu PR. Relation between biological IgA abnormalities and mesangial IgA deposits in isolated hematuria of childhood. Clin Nephrol. 1987; 8: 73–80.
  • Sakai H, Miyazaki M, Endoh M, Nomoto Y. Increase of IgA-spccific switch T cells in patients with IgA nephropathy. Clin Exp Immunol. 1989; 78: 378–82.
  • Schena FP, Mastrolitti G, Jirillo E, et al. Increased prouction of interleukin-2 and 11–2 receptor in primary IgA nephropathy. Kidney Int. 1989; 35: 8759.
  • Lai KN, Leung JC, Li PK, Lui SF. Cytokine production by peripheral blood mononuclear cells in IgA nephropathy. Clin Exp Immunol. 1991; 58: 240–5.
  • Casanueva B, Rodriguez-Valverde V, Farinas MC, Vallo A, Rodriguez-Soriano J. Autologous mixed lymphocyte reaction and T-cell suppressor activity in patients with Henoch-SchOnlein purpura and IgA nephropathy. Nephron. 1990; 54:2248.
  • Emancipator SN. Immunoregulatory factors in the pathogenesis of IgA nephropathy. Kidney Int. 1990;38:1216–29.
  • Davin JC, Li Vecchi M, Nagy J et al. Evidence that the interaction between circulating IgA and fibronectin is a normal process enhanced in IgA nephropathy. J Clin Immunol. 1991; 11: 78–94.
  • Davin JC, Dcchenne C, Lombet J, Rentier B, Foidart JB, Mahieu PR. Acute experimental glomerulonephritis induced by the glomerular deposition of circulating polymeric IgAconcanavalin A complexes. Virchows Archiv A Pathol Anat Histopathol. 1989;415:7–20.
  • Coppo R, Basolo B, Piccoli G, et al. IgAl and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schonlein nephritis. Clin Exp Immunol. 1984;57:583–90.
  • Czerkinsky C, Koopman WJ, Jackson S, ct al. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest 1986; 77: 1931–38.
  • Schena FP, Pastore A, LudovicoN, Sinico RA, Benuzzi S, Montinaro V. Increased levels of IgAl-IgG immune complexes and anti F(ab’)2 antibodies in patients with primary IgA nephropathy. Clin Exp Immunol. 1989; 77: 15–20.
  • Cederholm B, Wieslandcr J, Bygren P, Heinegard D. Circulating complexes containing IgA and fibroncctin in patients with primary IgA nephropathy. Proc Natl Acad Sci USA. 1988; 85: 4865–68.
  • Rifai A, Schena FP, Montinaro V et al. Clearance kinetics and fate of macromolecular IgA in patients with IgA nephropathy. Lab Invest. 1989; 61381–8.
  • Nicholls KM, Kincaid-Smith P. Defective in vivo Fc and C3b receptor function in IgA nephropathy. Am J Kidney Dis. 1984; 4: 128–34.
  • Davin JC, Vandenbroeck MC, Foidart JB, Mahieu PR. Sequential measurements of the reticulo-endothelial system function in Henoch-SchOnlein disease in childhood. Correlation with various immunological parameters. Acta Paediatr Scand. 1985;74:201–6.
  • Michael AF, Fish AJ, Good RA. Glomerular localization and transport of aggregated proteins in mice. Lab Invest. 1967; 17: 14–29.
  • Germuth FG, Rodriguez E. Immunopathology of the renal glomerulus. Little, Brown, Boston. 1973; p. 15 ff.
  • Batsford SR, Weghaupt R, Takamiya H, Vogt A. Studies on the mesangial handling of protein antigens: influence of size, charge and biologic activity. Nephron. 1985; 41: 146–51.
  • Jones CL, Powell HR, Kincaid-Smith P, Roberton DM. Polymeric IgA and immune complex concentrations in IgA-related renal disease. Kidney Int. 1990; 38: 323–31.
  • Rifai A, Small PA, Tcague PO, Ayoub EM. Experimental IgA nephropathy. J Exp Med. 1979; 50: 1161–73.
  • Davies M. The mesangial cell: a tissue culture view. Kidney Int. 1994; 45: 320–7.
  • Foidart J, Davin JC, Heinen E et al. Effects of lectins on the endocytic capacity of rat glomerular mesangial cells in culture. Ann Rheum Dis (in press).
  • Gommez-Guerrero C, Gonzalez E, Egido J. Evidence for a specific IgA receptor in rat and human mesangial cells. J Immunol. 1993; 151:7172–81.
  • Gesualdo L, Pinzani M, Floriano JJ et al. Platelet derived growth factor expression in mesangial pro-Iliferative glomerulonephritis. Lab Invest. 1991; 65: 160–7.
  • Horii Y, Muraguchi A, Iwano M, et al. Involvement of 11–6 in mesangial proliferative glomerulonephritis. J Immunol. 1989; 143: 3949–55.
  • Egido J. Julian B, Wyatt RJ. Genetic factors in IgA nephropathy. Nephrol Dial Transplant. 1987; 2: 134–42.
  • D’Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med. 1987; 245: 709–27.
  • Sakai H, Nomoto Y, Tomino Y, Endoh M, Miura M, Suga T. Increase of in vivo and in vitro production of polyclonal IgA in patients and their family members with IgA nephropathy. Adv Exp Med Biol. 1987; 216B: 1507–14.
  • Welch TR, Berry A, Beischel LS.C4 isotype deficiency in IgA nephropathy. Pediatr Nephrol. 1987; 1: 136.
  • Rambausek M, van den Wall Bake AWL, Schumacher-Ach R et al. Genetic polymorphism of C3 and Bf in IgA nephropathy. Nephrol Dial Transplant. 1987: 2: 208–11.
  • Demaine AG, Rambausek M, Knight JF, William DG, Welsh KI, Ritz E. Relation of mesangial IgA glomerulonephritis to polymorphism of immunoglobulin heavy chain switch region. J Clin Invest. 1988;81:611–4.
  • Montinaro V, Hevey K, Aventaggiato L et al. Extrarenal cytokines modulate the glomerular response to IgA immune complexes. Kidney Int. 1992; 42: 341–53.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.